Market Size (2018)
$2.70B
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2018)
$2.70B
Projected (2024)
$4.11B
CAGR (2016–2024)
7.3%
Key Players
10+
An ostomy (or stoma) is a surgical opening made in the skin as a way for waste products to leave the body. An ostomy can allow wastes to leave from the intestines (ileostomy or colostomy) or from the bladder (urostomy). The key factors responsible for driving the market are increasing prevalence of inflammatory bowel disease (IBD), increasing awareness about ostomy/stoma care and availability of accessories in the market, rising prevalence of colorectal cancer. However, negative psychological and emotional impacts of having ostomy/stoma and post-operative complications is hindering the growth rate of the global stoma or ostomy care Market. Nevertheless, factors such as unfavorable drug price control policies in many countries, increasing penetration of counterfeit drugs, and complex license renewal procedures hamper the market growth.
The Stoma or Ostomy Care Market market is projected to grow at a CAGR of 7.3% from 2016 to 2024.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansStoma or Ostomy Care Market
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
The scope of the global stoma or ostomy care market study includes the market size analysis and a detailed analysis of the manufacturers’ products and strategies. The market has been segmented based on type, application, and region.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2024
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2024)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe Global stoma or ostomy care market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive with all the players competing to gain the market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and to increase the global market share.
Vendors with better technical and financial resources can develop innovative products. Therefore, vendors must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their treatment lines in the market.
Coloplast Corp. (Coloplast) is a medical device company involved in developing and marketing healthcare products and services across the world. The company functions through three operating segments, namely, chronic care, interventional urology, and wound and skin care. It provides medical devices for ostomy care, continence care products, wound care products, and products for the surgical treatment of urological and gynecological disorders.
ConvaTec Inc. (ConvaTec) is a global medical products and technologies company. It has leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care. Its brands include AQUACEL advanced wound dressings. ConvaTec has 11 manufacturing sites in eight countries, and its business is spread in more than 100 countries.
Market estimates by geography (2024)
InsightEurope leads with $1.58B by 2024, while North America is projected to grow fastest at a 7.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2024 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $109.03M | $123.98M | $136.41M | 2.8% | 3% |
| North America | $836.62M | $1.13B | $1.53B | 7.8% | 37% |
| Asia Pacific | $340.81M | $458.06M | $613.94M | 7.6% | 15% |
| Europe | $889.61M | $1.19B | $1.58B | 7.4% | 38% |
| South America | $160.33M | $203.39M | $256.35M | 6.0% | 6% |
| Total | $2.34B | $3.10B | $4.11B | 7.3% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$4.11B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Two-Piece Systems | $2.27B | 7.2% | 55% |
| One-Piece Systems | $1.25B | 7.5% | 31% |
| Others | $588.31M | 7.5% | 14% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Stoma or Ostomy Care Market covering market dynamics, competitive landscape, and strategic outlook.
The Stoma or Ostomy Care Market market is projected to reach $4.11B by 2024, growing at 7.3% CAGR. The Two-Piece Systems segment holds the largest share.
The stoma or ostomy is a surgical opening created in the abdominal body to remove the disease associated to the digestive system. There are different types of ostomy operations such as colostomy, ileostomy, and urostomy which are performed depending on the position of disease.
In the ostomy surgery, the end part of the small or large intestine is brought to the surface of the skin through the surgically created opening to discharge the biological waste into an accessory such as a bags or pouch placed outside the body. This surgery is performed in the patient suffering from inflammatory bowel diseases (IBD) such as ulcerative colitis or Crohn’s disease, blockage or misfunctioning of the intestine or urinary tract, diverticular disease, infection, intestinal cancer, or in some accidental damage.
The major key factors driving the growth of this market are the increasing prevalence of inflammatory bowel disease (IBD) and colorectal cancer, increasing awareness about ostomy/stoma care and availability of accessories used to treat ostomy in the market, and stable reimbursement policies by both government and private organizations.
However, factors such as post-operative complications, negative psychological and emotional impacts of having ostomy/stoma, and risks associated with the ostomy surgery hinder the growth of the market.
The inflammatory bowel disease is a disorder related to digestive system which includes ulcerative colitis and Crohn's diseases. IBD are caused due the increased smoking habit, high consumption of alcohol, and stressed lifestyle among the population. The patient suffering IBD have to undergo ostomy or stoma surgery to cure the disease which cause an artificial opening to discharge the biological waste. According to the Centers for Disease Control and Prevention (CDC), 2019 data, 3 million of the US adults reported being diagnosed with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis) in 2015. Furthermore, in 2015 according to the CDC data 1.3 million people suffered from IBD in the US. Such a huge number of populations suffering from inflammatory bowel disease and related diseases increase the number of colostomy surgery and boosts the global stoma or ostomy care market.
The increasing prevalence of bowel/bladder cancer and problems related to small or large intestines have served as a good platform for manufacturers. There are many medical device companies involved in developing accessories used for ostomy care. The problems faced by patients related to stoma products which include leakage in the bags and pouches used by the stoma patient create several opportunities for manufacturers to develop new products. Besides this, there are huge opportunities for the development of the market in developing countries. B. Braun Medical SAS a part of B. Braun Group, launched Be 1 which is an alternative product for stoma patients. Thus, the development of innovative products can pose tons of opportunities for the growth of the market.
The post-operative or surgical complications may depend on patients and their medical conditions. Abdominal pain is common after surgery, but if not cured even after medication, it may cause serious problems to the patient’s health. The postoperative complications after colostomy include rectal bleeding, swelling, fever, infection, leakage around the stoma, and injury to surrounding organs during the procedure. Other complications include leakage of digestive waste from the colon in the abdomen or on the surrounding skin and skin problems where the skin surrounding the stoma becomes painful and causes irritation. According to Johns Hopkins University, parastomal hernias is the biggest complication caused by ostomy surgery. The complications mentioned above associated with the ostomy surgery affect the global ostomy or stoma care market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Stoma or Ostomy Care Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
ConvaTec Inc.
Company Headquarters: Reading, UK Founded: 1978 Workforce: 10,000 Company Working: Convatec Inc produces and sells medical equipment. It offers products for advanced wound, ostomy, continence, and infusion treatment for acute-care hospitals and chronic-care facilities. Infusion care, advanced wound care, ostomy care, continence, and critical care, and are the four main business categories that the company concentrates on. The company's main products include urological catheters, skin care products, disposable infusion sets, wound dressings, diabetes, ulcers, multiple sclerosis, spina bifida, and other devices and accessories. The company's main products include urological catheters, skin care products, disposable infusion sets, wound dressings, diabetes, ulcers, multiple sclerosis, spina bifida, and other devices and accessories. Additionally, it provides products directly and via a network of distributors to hospitals, homecare agencies, pharmacies, insulin pump makers, and retail distributors in the homecare industry. The corporation also operates business throughout the Americas, Europe, Asia-Pacific, Middle East, and Africa.
Coloplast Corp.
Company Headquarters: Humlebaek, Denmark Founded: 1954 Workforce: ~11,000 Company Working: Coloplast Corp. (Coloplast) is a medical device company that develops and markets healthcare products and services across the world. The company functions through three operating segments, namely, chronic care, interventional urology, and wound and skin care. It provides medical devices for ostomy care, continence care products, wound care products, and products for the surgical treatment of urological and gynecological disorders. Coloplast markets and sells its products and services globally. Products are supplied to hospitals, institutions as well as wholesalers, distributors, and pharmacies. In selected markets, it is also a direct supplier to users. It has wholly-owned sales subsidiaries in its principal markets and employed about 12,000 people at the end of 2018.
Smith & Nephew
Company Headquarter: London, UK Founded: 1856 Workforce: 15000 employees Company Working: Smith & Nephew develops and markets medical devices worldwide. The company operates through four segments, namely, sports medicine, trauma, orthopedic reconstruction, and advanced wound management. The company primarily serves the providers of medical and surgical treatments and services. In 2014, Smith & Nephew acquired ArthroCare to broaden its sports medicine segment. The company has also acquired Healthpoint Biotherapeutics, which specializes in the production of bioactive for advanced wound management. Smith & Nephew has its presence in more than 100 countries and has major manufacturing units in the US, the UK, Switzerland, Germany, and China.
Tytex A/S
Company Headquarters: Ikast, Denmark Founded: 1971 Workforce: 550 Company Working: Tytex A/S is a world-leading company within medical fixation and compression textiles. The company is focused on developing, producing and selling textiles for special medical needs ranging from post-operation care to incontinence and maternity care. The products are developed to make the lives of users safer and easier. They partner with distributors and with healthcare companies interested in private label products. Tytex A/S is the parent company, with sales divisions in Denmark, the US, Germany and Thailand, as well as sales representatives who cover the entire world. Their production facilities are located in Slovakia.
Marlen Manufacturing & Development Co.
Company Headquarters: Ohio, US Founded: 1952 Workforce: ~ 200 Company Working: Marlen Manufacturing & Development Company manufactures and sells medical equipment and supplies for ostomy care. The company offers post-operative pouches, lightweight, odor-proof plastic pouches, double-sided sticky tape discs, and accessories. The company also provides Ileostomy, Colostomy, and Urostomy, one-piece ostomy products such as the MiniMax, UltraMax, and MaxPlus, the latter of which has a larger cutting surface of up to 80mm. Additionally, Vancive Medical Technologies' cutting-edge InteliShield Barrier Film, which has a patent application pending, is employed in the creation of Marlen Ostomy Pouches. It also operates in the US, Canada, Europe, the UK, the Netherlands, and Japan.
Welland Medical Limited
Company Headquarters: Crawley, West Sussex Founded: 1988 Workforce: 201-500 Company Working: Welland Medical Limited is a British manufacturing company, and one of the leading ostomy brands in UK and across the globe. The company specializes in stoma care, specialising in the design, development and manufacturing of stoma care appliances and accessories. Welland Medical Limited constantly provide quality products, which has produced with utmost focus on quality. The company has been expanding in global market over last 25 years and have built knowledge and expertise in specific customer requirements across the globe.
12 interactive charts drawn from the Stoma or Ostomy Care Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Stoma or Ostomy Care Market By Region
Global Stoma or Ostomy Care Market South America Of South America
Global Stoma or Ostomy Care Market Germany, Spain, France, United Kingdom, Italy and Rest Of Europe By Country
Global Stoma or Ostomy Care Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country
Global Stoma or Ostomy Care Market United States and Canada Of North America By Country
Global Stoma or Ostomy Care Market Middle East And Africa Of Middle East And Africa
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence